X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (2) 2
aged (2) 2
aged, 80 and over (2) 2
care and treatment (2) 2
female (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
middle aged (2) 2
oncology (2) 2
tumors (2) 2
1874-1963 (1) 1
1st-line treatment (1) 1
adenocarcinoma (1) 1
administration, intravenous (1) 1
administration, oral (1) 1
adolescent (1) 1
american poetry concordances (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
asia (1) 1
ca-19-9 antigen - blood (1) 1
cancer (1) 1
carboplatin - administration & dosage (1) 1
carboplatin-paclitaxel (1) 1
carcinoembryonic antigen - blood (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
chemotherapy (1) 1
chi-square distribution (1) 1
cisplatin - administration & dosage (1) 1
clinical trials (1) 1
clinicopathological features (1) 1
concordances (1) 1
concordances. frost, robert, 1874-1963 (1) 1
copd (1) 1
critical care medicine (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
dilatation, pathologic - pathology (1) 1
disease-free survival (1) 1
dna mutational analysis (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug effects (1) 1
drug therapy (1) 1
egfr (1) 1
emphysema (1) 1
endosonography (1) 1
erlotinib hydrochloride (1) 1
ethics (1) 1
frost, robert (1) 1
frost, robert, 1874-1963 (1) 1
frost, robert, 1874-1963 concordances (1) 1
frost, robert, concordances (1) 1
gefitinib (1) 1
genetic predisposition to disease (1) 1
health (1) 1
hematology, oncology and palliative medicine (1) 1
japan (1) 1
jaundice, obstructive - etiology (1) 1
kaplan-meier estimate (1) 1
lesions (1) 1
lung cancer, non-small cell (1) 1
lung function (1) 1
lung neoplasms - drug therapy (1) 1
lung neoplasms - enzymology (1) 1
lung neoplasms - genetics (1) 1
lung neoplasms - mortality (1) 1
lung neoplasms - pathology (1) 1
lung volume reduction surgery (1) 1
magnetic resonance imaging (1) 1
malignancy (1) 1
management (1) 1
maximum exercise capacity (1) 1
median sternotomy (1) 1
medical colleges (1) 1
medical vs surgical treatment (1) 1
medicine & public health (1) 1
memory (1) 1
memory disorders (1) 1
metaanalysis (1) 1
multicenter (1) 1
mutation (1) 1
neoplasms, cystic, mucinous, and serous - classification (1) 1
neoplasms, cystic, mucinous, and serous - diagnostic imaging (1) 1
neoplasms, cystic, mucinous, and serous - pathology (1) 1
nsclc (1) 1
observe (1) 1
obstructive pulmonary-disease (1) 1
open-label (1) 1
pancreatic ducts - diagnostic imaging (1) 1
pancreatic ducts - pathology (1) 1
pancreatic neoplasms - classification (1) 1
pancreatic neoplasms - diagnostic imaging (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 777 - 786
Summary Background The results of FASTACT, a randomised, placebo-controlled, phase 2 study, showed that intercalated chemotherapy and erlotinib significantly... 
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | THERAPY | NSCLC | ONCOLOGY | ADENOCARCINOMA | OPEN-LABEL | EGFR | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Time Factors | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genetic Predisposition to Disease | Lung Neoplasms - enzymology | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Administration, Intravenous | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Clinical trials | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 6/2014, Volume 21, Issue 6, pp. 1919 - 1926
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.